ATLANTA, GA - June 15, 2015
- LED Medical Diagnostics Inc. ("LED Medical" or "the Company") has announced an agreement that makes LED Medical subsidiary LED Dental the newest provider of 3Shape's 3D intraoral digital impression and desktop scanners.
Under the terms of the agreement, LED Dental will become a distributor to the orthodontic market for the TRIOS line of products, including the new TRIOS 3 digital impressioning system introduced by 3Shape during the 2015 IDS Exhibition. Boasting a new, more compact hand-piece design, RealColor TM
intraoral photography, and flexible hardware configurations, the TRIOS 3 can perform a variety of digital tasks for both general dental and orthodontic practices.
"Since building our digital imaging product portfolio over a year ago, weve had a great deal of success in the orthodontic space, which is where we plan to focus our efforts for the 3Shape TRIOS product line," stated Lamar Roberts, president of LED Dental. "3Shapes state-of-the-art digital impressioning technologies strengthen our product portfolio, allowing us to offer orthodontists the very best digital technology available to facilitate a patients diagnosis, treatment planning and subsequent treatment."
Dr. Jeffrey Brooks, vice president of imaging for LED Dental, sees the myriad of benefits that come with introducing intraoral scanning technologies during the planning of orthodontic treatments. "Utilizing 3Shapes advanced scanning technologies and related software opens up digital workflow for the orthodontist." Dr. Brooks continued, "The capability to quickly acquire full color 3D scans of the patients dentition and related structures negates the need for putty impressions and gypsum models and opens up new opportunities for diagnosis, treatment simulation and patient understanding. 3Shape scans also integrate and index with the patients CBCT image data allowing practitioners to take much of the guesswork out of treatment planning."
Dr. David Gane, CEO of LED Medical Diagnostics, concludes: "The addition of 3Shape products to our imaging portfolio, our first measured step into dental CAD/CAM, is a prime example of how we are executing to grow revenues by creating additional and diverse revenue streams, while leveraging our sales and marketing infrastructure."
For more information on LED Dental or a demonstration of the full line of TRIOS intraoral scanners, please visit www.leddental.com
or call 844.952.7327.
For more information on 3Shape and the TRIOS scanner, please visit www.3shape.com
About LED Medical Diagnostics Inc.
Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd, provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.
The Company is currently listed on the TSX Venture Exchange (TSX-V) under the symbol LMD, the OTCQX under the symbol LEDIF, as well as the Frankfurt Stock Exchange under the symbol LME. For more information, call 844.952.7327 or visit www.leddental.com/investor-relations
LED Medical Diagnostics
David Gane, CEO
Phone: 604-434-4614 x227
Forward Looking Statement
This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company's future growth strategy, its distribution strategy and product offerings, potential expansion of the Company's technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2014. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.